Publications

Article

Time-Driven Activity-Based Costing in Emergency Medicine

By: Robert S. Kaplan, Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey and Ali S. Raja

Value in emergency medicine is determined by both patient-important outcomes and the costs associated with achieving them. However, measuring true costs is challenging. Without an understanding of costs, emergency department (ED) leaders will be unable to determine... View Details

Keywords: Time-Driven Activity-Based Costing; Emergency Room; Health Care and Treatment; Value; Cost Management; Activity Based Costing and Management

Read Now

2020
Working Paper

Revenue Collapses and the Consumption of Small Business Owners in the Early Stages of the COVID-19 Pandemic

By: Olivia S. Kim, Jonathan A. Parker and Antoinette Schoar

Using detailed transaction-level data from financial accounts, this paper shows that the revenues of small businesses and the consumption spending of their owners both decline by roughly 40% following the declaration of the national emergency in March 2020. However,... View Details

Keywords: Revenue; Small Business; Health Pandemics; Spending

Find at Harvard

September 2023 (Revised January 2024)
Case

AB InBev: Brewing Up Forecasts during COVID-19

By: Mark Egan, C. Fritz Foley, Esel Cekin and Emilie Billaud

In July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a workforce of 160,000 in 2020, AB InBev... View Details

24 Jun 2014
First Look

First Look: June 24

http://howardgardner.com/2014/05/27/mind-work-and-life/ August 2013 Journal of Political Economy Poultry in Motion: A Study of International Trade Finance Practices By: Antràs, Pol, and C. Fritz Foley Abstract—This paper analyzes the... View Details

Keywords: Sean Silverthorne

24 Oct 2006
First Look

First Look: October 24, 2006

and AIDS: The Macroeconomic Impact of a Health Crisis Authors:Eric D. Werker, Amrita Ahuja, and Brian Wendell Abstract Theories abound on the potential macroeconomic impact of AIDS in Africa, yet there have been surprisingly few empirical... View Details

Keywords: Sean Silverthorne

24 Apr 2018
First Look

First Look at New Research and Ideas, April 24, 2018

In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare... View Details

Keywords: Sean Silverthorne

03 Apr 2012
First Look

First Look: April 3

leadership development programs for residents. The authors first present a definition of clinical leadership and highlight evidence that effective frontline clinical leadership improves both clinical outcomes and satisfaction for patients and providers. The authors... View Details

Keywords: Carmen Nobel

Article

Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt

Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details

Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States

September 2010
Teaching Note

Acumen Fund: Measurement in Impact Investing (TN) (A) and (B)

By: Alnoor Ebrahim

Teaching Note for 310011 and 310017. View Details

Keywords: Projects; For-Profit Firms; Networks; Health Care and Treatment; Performance Evaluation; Investment Portfolio; Asset Pricing; Competition; Multinational Firms and Management; Venture Capital; Investment Return; Poverty; Financial Services Industry; Kenya

August 2001
Case

Scios, Inc.

By: Regina E. Herzlinger

Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Cost Management; Cost vs Benefits; Social Issues; Pharmaceutical Industry; United States

08 Sep 2009
Research & Ideas

The Height Tax, and Other New Ways to Think about Taxation

health insurance may delay its arrival. Q: How is your idea of a height tax greeted among economists and policymakers? How do you address potential criticisms as mentioned in your paper, such as fears about a slippery slope leading to... View Details

Keywords: by Martha Lagace

06 May 2014
First Look

First Look: May 6

http://hbr.org/product/pepsico-india-performance-with-purpose/an/512041-PDF-ENG Harvard Business School Case 614-039 A Note on Funding Digital Innovation Startups This note provides information on the state of startup financing in Silicon... View Details

Keywords: Sean Silverthorne

September 2024
Case

Myeloma Investment Fund

By: Kyle Myers and Scott Sawaya

This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.

The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details

Keywords: Venture Philanthropy; Biomedical Research; Investing For Impact; Innovation ＆ Entrepreneurship; Venture Capital; Science-Based Business; Philanthropy and Charitable Giving; Decision Making; Health Care and Treatment; Biotechnology Industry; Pharmaceutical Industry

June 2020 (Revised February 2021)
Supplement

Accounting for Leases at American Airlines (B)

By: Jonas Heese, Gerardo Pérez Cavazos and Julia Kelley

This is a supplement to the “Accounting for Leases at American Airlines (A)” case. The (B) case describes American Airlines’ financial results for the first quarter of 2020, as well as the continuing effects of coronavirus on the airline industry. View Details

Keywords: Accounting; Financial Reporting; Financial Statements; Finance; Governance; Corporate Accountability; Corporate Governance; Governing Rules, Regulations, and Reforms; Governing and Advisory Boards; Leasing; Health Pandemics; Accounting Industry; Air Transportation Industry; North and Central America; United States